Sleep as a Novel Biomarker and a Promising Therapeutic Target for Cerebral Small Vessel Disease: A Review Focusing on Alzheimer’s Disease and the Blood-Brain Barrier

Cerebral small vessel disease (CSVD) is a leading cause of cognitive decline in elderly people and development of Alzheimer’s disease (AD). Blood–brain barrier (BBB) leakage is a key pathophysiological mechanism of amyloidal CSVD. Sleep plays a crucial role in keeping health of the central nervous s...

Descripción completa

Detalles Bibliográficos
Autores principales: Semyachkina-Glushkovskaya, Oxana, Postnov, Dmitry, Penzel, Thomas, Kurths, Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504101/
https://www.ncbi.nlm.nih.gov/pubmed/32878058
http://dx.doi.org/10.3390/ijms21176293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504101/
https://www.ncbi.nlm.nih.gov/pubmed/32878058
http://dx.doi.org/10.3390/ijms21176293

Ejemplares similares